Fine Organic Industries
Fine Organic Industries
ChemicalsKey Fundamentals
SmallcapSpecialty ChemicalsChemicalsTapetide Score
Data-driven rating, 0–100. How it works →
Key Insights
Strengths
2- Company is almost debt free.
- Company has a good return on equity (ROE) track record: 3 Years ROE 19.5%
Growth Rate
AI Analysis — Bull vs Bear
Fine Organic Industries has a market cap of about ₹15,578 crore and trades at a P/E of 35.5x and a P/B of 5.83x. It has a strong long-term record, with 5-year compounded sales growth of 16%, profit growth of 28% and an average ROE of 25%. More recently, 3-year sales fell at an 8% annual rate and profit at 13%, and ROE dropped to 16% last year, though TTM sales and profit are both up 7%.
- The company is almost debt-free, and its 3-year average ROE of about 19.5% was achieved without meaningful leverage.
- Returns have held up over the long run: 5-year and 10-year average ROE are both 25%, which suggests a durable competitive position in specialty additives.
- Profit compounded at 28% a year over 5 years and 18% a year over 10 years, showing strong earnings growth across multiple cycles.
- Sales compounded at 14% a year over 10 years and 16% over 5 years, which points to steady long-term demand for its products.
- Growth has turned positive again, with TTM sales and profit each up 7%, after both fell over the 3-year period (-8% and -13%).
- With a P/B of 5.83x, implied book value is about ₹2,672 crore. A clean, low-debt balance sheet gives room to fund capacity expansion from internal resources.
- The stock is up 10% over 1 year, compared with a 1% CAGR over 3 years, which may reflect improving sentiment as earnings recover.
- Over 3 years, sales fell at an 8% annual rate and profit at 13%, a sharp reversal from the 5-year growth rates of 16% and 28%.
- ROE fell to 16% last year, down from a 25% 5-year average and 19% 3-year average, so returns on capital are shrinking.
- A P/E of 35.5x gives an earnings yield of only about 2.8%. That is a premium multiple for a business whose TTM profit growth is just 7%.
- A P/B of 5.83x combined with a 16% ROE means investors are paying a high price for each rupee of book value while returns are falling.
- The stock has returned only a 1% CAGR over 3 years, which reflects the valuation de-rating that came with the earnings decline.
- The dividend yield is only 0.22%, which implies a payout ratio of roughly 8% at a P/E of 35.5x. That offers little income support if growth disappoints.
- The profit decline over 3 years (-13% CAGR) was steeper than the sales decline (-8% CAGR), which suggests margins are sensitive to raw material costs and pricing.
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
- 80% stake in Malaysian Oleofine Sep 2
Fine Organic signed share transfer agreements to buy an 80% equity stake in Oleofine Organics SDN. BHD for up to RM 3.42 crore in cash. The deal expands its specialty chemicals presence overseas.
- ₹55 Cr into SEZ subsidiary Sep 16
The company subscribed to ₹55 crore of preference shares in its wholly owned subsidiary, Fine Organic Industries (SEZ) Pvt Ltd, to fund a new manufacturing setup. This points to capacity expansion ahead.
- Promoter stake via HUF partition Sep 22
Promoter Jayen Ramesh Shah received 3,06,978 shares from Jayen R Shah HUF through an inter-se, off-market transfer with no consideration, which takes his stake to 17.04%. Disclosures on Sep 8 and Sep 22 cover the same transaction, and total promoter group holding stays the same.
- Investor conferences on Sep 21, 29 Sep 16
Management will attend in-person investor conferences on Sep 21, 2026 (Anand Rathi) and Sep 29, 2026 (PL Capital). It has also uploaded its August 2026 investor presentation.
TL;DR: Fine Organic is putting money into growth: it is buying 80% of Malaysia's Oleofine Organics for up to RM 3.42 crore and investing ₹55 crore in its SEZ manufacturing subsidiary. These news items show no clear headwinds, and the promoter share transfer is an internal HUF partition that leaves group ownership unchanged. The main risks are carrying out the capex and integrating the overseas acquisition, and these articles say nothing about demand or margins. The trend looks steady to improving, and the Sep 21 and Sep 29 investor meetings could give more detail on when the new capacity and Malaysian operations will start adding to earnings.
Quarterly Results
| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 547 | 540 | 488 | 547 | 550 | 596 | 517 | 607 | 588 | 597 | 555 | 625 | 694 |
| Expenses | 407 | 410 | 371 | 403 | 410 | 446 | 414 | 487 | 466 | 463 | 461 | 496 | 520 |
| Operating Profit | 140 | 130 | 117 | 144 | 139 | 150 | 103 | 120 | 123 | 134 | 94 | 129 | 174 |
| OPM % | 26% | 24% | 24% | 26% | 25% | 25% | 20% | 20% | 21% | 22% | 17% | 21% | 25% |
| Other Income | 14 | 17 | 17 | 22 | 24 | 22 | 25 | 26 | 47 | 21 | 21 | 35 | 24 |
| Interest | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 3 | 1 |
| Depreciation | 12 | 14 | 15 | 15 | 12 | 13 | 13 | 15 | 12 | 13 | 14 | 18 | 14 |
| PBT | 143 | 132 | 119 | 150 | 151 | 159 | 115 | 130 | 157 | 142 | 101 | 143 | 184 |
| Tax % | 30% | 22% | 21% | 24% | 25% | 26% | 28% | 25% | 26% | 24% | 27% | 18% | 25% |
| Net Profit | 100 | 103 | 94 | 115 | 113 | 117 | 83 | 97 | 117 | 109 | 74 | 117 | 138 |
| EPS in Rs | 32.54 | 33.71 | 30.73 | 37.36 | 36.94 | 38.3 | 26.97 | 31.68 | 38.19 | 35.4 | 24.11 | 38.32 | 45.06 |
Profit & Loss
| Particulars | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 660 | 778 | 856 | 1,060 | 1,038 | 1,133 | 1,876 | 3,023 | 2,123 | 2,269 | 2,366 | 2,472 |
| Expenses | 514 | 633 | 697 | 827 | 803 | 935 | 1,513 | 2,194 | 1,591 | 1,757 | 1,886 | 1,941 |
| Operating Profit | 146 | 145 | 158 | 234 | 235 | 198 | 363 | 829 | 532 | 512 | 480 | 531 |
| OPM % | 22% | 19% | 19% | 22% | 23% | 17% | 19% | 27% | 25% | 23% | 20% | 21% |
| Other Income | 8 | 4 | 16 | 20 | 20 | 17 | 33 | 64 | 71 | 98 | 124 | 101 |
| Interest | 7 | 4 | 3 | 2 | 5 | 6 | 5 | 5 | 2 | 2 | 4 | 4 |
| Depreciation | 30 | 24 | 20 | 17 | 35 | 47 | 40 | 48 | 57 | 52 | 56 | 58 |
| PBT | 117 | 121 | 151 | 234 | 216 | 162 | 352 | 841 | 544 | 555 | 543 | 569 |
| Tax % | 35% | 36% | 37% | 40% | 24% | 26% | 26% | 26% | 24% | 26% | 23% | — |
| Net Profit | 76 | 78 | 95 | 136 | 165 | 120 | 260 | 618 | 412 | 410 | 417 | 438 |
| EPS in Rs | 158 | 161 | 31.09 | 44.43 | 53.74 | 39.24 | 84.67 | 202 | 134 | 134 | 136 | 143 |
| Div. Payout % | 29% | 9% | 23% | 16% | 13% | 28% | 11% | 4% | 7% | 8% | 8% | — |
Balance Sheet
| Particulars | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 5 | 5 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 |
| Reserves | 249 | 323 | 380 | 485 | 604 | 716 | 944 | 1,526 | 1,906 | 2,280 | 2,649 |
| Borrowings | 102 | 40 | 54 | 128 | 125 | 89 | 59 | 29 | 4 | 3 | 68 |
| Other Liabilities | 63 | 76 | 81 | 74 | 108 | 127 | 219 | 237 | 182 | 206 | 266 |
| Total Liabilities | 419 | 445 | 530 | 702 | 852 | 948 | 1,236 | 1,807 | 2,108 | 2,504 | 2,999 |
| Fixed Assets | 125 | 97 | 88 | 78 | 217 | 196 | 229 | 214 | 268 | 363 | 388 |
| CWIP | 6 | 3 | 32 | 106 | 6 | 26 | 14 | 40 | 30 | 27 | 64 |
| Investments | 0 | 11 | 11 | 10 | 33 | 31 | 31 | 39 | 36 | 35 | 38 |
| Other Assets | 289 | 334 | 399 | 508 | 597 | 694 | 962 | 1,513 | 1,774 | 2,078 | 2,508 |
| Total Assets | 419 | 445 | 530 | 702 | 852 | 948 | 1,236 | 1,807 | 2,108 | 2,504 | 2,999 |
Cash Flow
| Particulars | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | — | 45 | 65 | 98 | 219 | 134 | 67 | 485 | 635 | 204 | 430 |
| Investing | — | -16 | -52 | -93 | -85 | -40 | -32 | -128 | -396 | -675 | -430 |
| Financing | — | -55 | -17 | 92 | -37 | -41 | -68 | -69 | -59 | -35 | 0 |
| Net Cash Flow | — | -26 | -3 | 97 | 98 | 53 | -33 | 289 | 180 | -506 | -1 |
| Free Cash Flow | — | 34 | 13 | 5 | 146 | 88 | 6 | 405 | 549 | 77 | 288 |
| CFO/OP | — | 65 | 73 | 79 | 119 | 89 | 41 | 86 | 148 | 68 | 116 |
Ratios
| Particulars | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 49 | 52 | 62 | 54 | 47 | 52 | 59 | 42 | 54 | 54 | 54 |
| Inventory Days | 72 | 68 | 58 | 50 | 79 | 63 | 72 | 91 | 78 | 100 | 104 |
| Days Payable | 50 | 47 | 46 | 30 | 51 | 49 | 47 | 36 | 41 | 43 | 45 |
| Cash Conversion Cycle | 71 | 72 | 75 | 74 | 74 | 66 | 84 | 97 | 91 | 111 | 113 |
| Working Capital Days | 80 | 69 | 80 | 76 | 63 | 65 | 79 | 76 | 77 | 104 | 92 |
| ROCE % | — | 35% | 38% | 44% | 32% | 22% | 39% | 65% | 31% | 26% | 21% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Fine Organic Industries insights
63 extracted metrics + investor summaries across FY15–FY27.
Documents
Frequently Asked Questions about Fine Organic Industries
What does Fine Organic Industries Ltd do?
Where is Fine Organic Industries Ltd (FINEORG) listed?
Which sector does Fine Organic Industries Ltd belong to?
What is the market capitalisation of Fine Organic Industries Ltd?
What is the PE ratio of Fine Organic Industries Ltd?
What is the 52-week high and low of Fine Organic Industries Ltd?
Does Fine Organic Industries Ltd pay dividends?
What is the Return on Equity (ROE) of Fine Organic Industries Ltd?
Company Information
Fine Organic Industries is engaged in and outside India as manufacturers, processors, suppliers, distributors, dealers, importers, exporters of wide range of oleochemical-based additives used in foods, plastics, cosmetics, coatings and other specialty application in various industries.
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/FINEORG.md for Fine Organic Industries Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.